Details for Patent: 4,946,853

✉ Email this page to a colleague

Summary for Patent: 4,946,853

Title:	Method for the treatment of withdrawal symptoms associated with smoking cessation and preparations for use in said method
Abstract:	A preparation for the once-daily, percutaneous administration of nicotine comprises nicotine uniformly distributed in a solid, semi-solid or mucilaginous medium which can be placed in intimate contact with the skin, the solid, semi-solid or mucilaginous medium is formed by adding a given amount of nicotine to a solution of a solidifying or gel-forming agent or mixture thereon in a suitable solvent or mixture of solvents and mixing or heating the mixture thereby obtained so as to form the solid, semi-solid or mucilaginous medium. The preparation can be used in a method of treating withdrawal symptoms associated with smoking cessation and for combating the psychological dependence that occurs through frequency smoking.
Inventor(s):	Bannon; Yvonne B. (Naas, IE), Corish; John (Leopardstown, IE), Corrigan; Owen I. (Howth, IE), Geoghegan; Edward J. (Athlone, IE), Masterson; Joseph G. (Dublin, IE)
Assignee:	Elan Transdermal Limited (Athlone, IE)
Application Number:	07/188,226
Patent Claim Types: see list of patent claims	Formulation; Compound; Device; Use;

Drugs Protected by US Patent 4,946,853

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 4,946,853

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Ireland	1119/87	May 01, 1987
Ireland	1946/87	Jul 17, 1987

International Family Members for US Patent 4,946,853

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	161721	⤷ Sign Up
Australia	1534988	⤷ Sign Up
Australia	607214	⤷ Sign Up
Canada	1333051	⤷ Sign Up
Germany	3856096	⤷ Sign Up
Denmark	235088	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.